NewZ NewZ with a Zeal
Aveo shares rose 17% Thursday morning, pointing to a second day of strong gains. The stock climbed 89% in the previous session after the FDA approval its renal cancer treatment. Aveo plans to make its Fotivda treatment available to US patients at the end …
Related Articles
Check Also
Cranes Market to Reach USD 45.80 billion by 2027; Surging Mining Activities to Aid Expansion, Fortune Business Insights™
Manitowoc Company, SANY GROUP (China), (U.S.), Tadano Ltd (Japan), Komatsu Ltd (Japan), Terex Corporation (U.S.), …
Sydney man quits law job as resume writing side hustle hits $400k
A Sydney man has quit his job in law after his side hustle outstripped his …